Volume 272, Number 2,
Issue of January 10, 1997
pp. 1069-1075
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Cell-permeable Ceramides Prevent the Activation of Phospholipase
D by ADP-ribosylation Factor and RhoA
(Received for publication, May 24, 1996, and in revised form, October 30, 1996)
Abdelkarim
Abousalham
,
Christos
Liossis
,
Lori
O'Brien
and
David N.
Brindley
From the Department of Biochemistry (Signal Transduction
Laboratories) and the Lipid and Lipoprotein Research Group, University
of Alberta, Edmonton, Alberta T6G 2S2, Canada
The mechanism of inhibition of phospholipase D
(PLD) by ceramides was determined using granulocytes differentiated
from human promyelocytic leukemic (HL-60) cells. In a cell-free system,
hydrolysis of phosphatidylcholine by membrane-bound PLD depended upon
phosphatidylinositol 4,5-bisphosphate, guanosine
5
-3-O-(thio)triphosphate) (GTP
S), and cytosolic factors
including ADP-ribosylating factor (ARF) and RhoA. C2-
(N-acetyl-), C8- (N-octanoyl-), and
long-chain ceramides, but not dihydro-C2-ceramide,
inhibited PLD activity. Apyrase or okadaic acid did not modify the
inhibition of PLD by ceramides, indicating that the effect in the
cell-free system was unlikely to be dependent upon a
ceramide-stimulated kinase or phosphoprotein phosphatases.
C2- and C8-ceramides prevented the
GTP
S-induced translocation of ARF1 and RhoA from the cytosol to the
membrane fraction. In whole cells, C2-ceramide, but not
dihydro-C2-ceramide, inhibited the stimulation of PLD by
N-formylmethionylleucylphenylalanine and decreased the
amounts of ARF1, RhoA, CDC42, Rab4, and protein kinase C-
and
-
1 that were associated with the membrane fraction, but
did not alter the distribution of protein kinase C-
and -
. It is
concluded that one mechanism by which ceramides prevent the activation
of PLD is inhibition of the translocation to membranes of G-proteins
and protein kinase C isoforms that are required for PLD activity.